Précisez une action ou une cryptomonnaie dans la barre de recherche pour obtenir un récapitulatif
Zydus Lifesciences Limited
ZYDUSLIFEZydus Lifesciences Limited engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, and internationally. It operates through two segments: Pharmaceuticals and Consumer Products. It offers finished dosage human formulations, such as generics; branded generics; specialty formulations, including biosimilars and vaccines; active pharmaceutical ingredients; consumer wellness products; animal healthcare products; and products in the therapeutic areas of pain management, neurology, metabolic disorder, and liver diseases. The company provides the products under the Everyuth, Nutralite, SugarFree, Complan, Glucon-D, and Nycil brands. In addition, the company offers a pipeline of biological products in the areas of oncology, autoimmune disease, nephrology, inflammation, rheumatology, hepatology, and infectious illnesses. Further, it engages in the investment, animal health and veterinary, pharmacy retail, and manpower supply and administration activities. The company was formerly known as Cadila Healthcare Limited and changed its name to Zydus Lifesciences Limited in February 2022. Zydus Lifesciences Limited was founded in 1952 and is headquartered in Ahmedabad, India. Zydus Lifesciences Limited is a subsidiary of Zydus Family Trust. Address: Zydus Corporate Park, Ahmedabad, India, 382481
Analytics
Objectif de Cours de WallStreet
91 374.16 INRRatio C/B
22.2238Rendement du dividende
0.32 %Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Chiffres clés ZYDUSLIFE
Analyse des dividendes ZYDUSLIFE
Croissance des dividendes sur 5 ans
71 %Croissance continue
1 annéeRatio de distribution Moyenne sur 5 ans
21 %Historique des dividendes ZYDUSLIFE
Valorisation des titres ZYDUSLIFE
financières ZYDUSLIFE
Résultats | 2019 | Dynamique |